Literature DB >> 18192054

RNAi: a powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycle.

Joachim Lupberger1, Laurent Brino, Thomas F Baumert.   

Abstract

Cellular cofactors affecting hepatitis C virus infection and replication. Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets KE, Pfeffer S, Landthaler M, Landgraf P, Kan S, Lindenbach BD, Chien M, Weir DB, Russo JJ, Ju J, Brownstein MJ, Sheridan R, Sander C, Zavolan M, Tuschl T, Rice CM. Recently identified hepatitis C virus (HCV) isolates that are infectious in cell culture provide a genetic system to evaluate the significance of virus-host interactions for HCV replication. We have completed a systematic RNAi screen wherein siRNAs were designed that target 62 host genes encoding proteins that physically interact with HCV RNA or proteins or belong to cellular pathways thought to modulate HCV infection. This includes 10 host proteins that we identify in this study to bind HCV NS5A. siRNAs that target 26 of these host genes alter infectious HCV production >3-fold. Included in this set of 26 were siRNAs that target DICER, a principal component of the RNAi silencing pathway. Contrary to the hypothesis that RNAi is an antiviral pathway in mammals, as has been reported for subgenomic HCV replicons, siRNAs that target DICER inhibited HCV replication. Furthermore, siRNAs that target several other components of the RNAi pathway also inhibit HCV replication. MicroRNA profiling of human liver, human hepatoma Huh7.5 cells, and Huh7.5 cells that harbor replicating HCV demonstrated that miR-122 is the predominant microRNA in each environment. miR-122 has been previously implicated in positively regulating the replication of HCV genotype 1 replicons. We find that 2'-O-methyl antisense oligonucleotide depletion of miR-122 also inhibits HCV genotype 2a replication and infectious virus production. Our data define 26 host genes that modulate HCV infection and indicate that the requirement for functional RNAi for HCV replication is dominant over any antiviral activity this pathway may exert against HCV. [Abstract reproduced by permission of Proc Natl Acad Sci USA 2007;104:12884-12889]

Entities:  

Year:  2007        PMID: 18192054     DOI: 10.1016/j.jhep.2007.12.007

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  10 in total

Review 1.  Extracellular microRNA: a new source of biomarkers.

Authors:  Alton Etheridge; Inyoul Lee; Leroy Hood; David Galas; Kai Wang
Journal:  Mutat Res       Date:  2011-03-23       Impact factor: 2.433

2.  Host-encoded reporters for the detection and purification of multiple enveloped viruses.

Authors:  Robin Ketteler; Vesselin Tomov; Alina Neunkirchner; Qiang Xie; Winfried F Pickl; Brian Seed
Journal:  J Virol Methods       Date:  2010-04-23       Impact factor: 2.014

3.  microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma.

Authors:  Julja Burchard; Chunsheng Zhang; Angela M Liu; Ronnie T P Poon; Nikki P Y Lee; Kwong-Fai Wong; Pak C Sham; Brian Y Lam; Mark D Ferguson; George Tokiwa; Ryan Smith; Brendan Leeson; Rebecca Beard; John R Lamb; Lee Lim; Mao Mao; Hongyue Dai; John M Luk
Journal:  Mol Syst Biol       Date:  2010-08-24       Impact factor: 11.429

4.  Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs.

Authors:  Aly A Khan; Doron Betel; Martin L Miller; Chris Sander; Christina S Leslie; Debora S Marks
Journal:  Nat Biotechnol       Date:  2009-06       Impact factor: 54.908

5.  Connecting rules from paired miRNA and mRNA expression data sets of HCV patients to detect both inverse and positive regulatory relationships.

Authors:  Renhua Song; Qian Liu; Tao Liu; Jinyan Li
Journal:  BMC Genomics       Date:  2015-01-21       Impact factor: 3.969

6.  Inhibition of Junín virus replication by small interfering RNAs.

Authors:  María C Artuso; Paula C Ellenberg; Luis A Scolaro; Elsa B Damonte; Cybele C García
Journal:  Antiviral Res       Date:  2009-07-08       Impact factor: 5.970

7.  Chitosan hydrogel as siRNA vector for prolonged gene silencing.

Authors:  Zhiwei Ma; Chuanxu Yang; Wen Song; Qintao Wang; Jørgen Kjems; Shan Gao
Journal:  J Nanobiotechnology       Date:  2014-06-19       Impact factor: 10.435

8.  Effective inhibition of hepatitis E virus replication in A549 cells and piglets by RNA interference (RNAi) targeting RNA-dependent RNA polymerase.

Authors:  Fen Huang; Xiuguo Hua; Shixing Yang; Congli Yuan; Wen Zhang
Journal:  Antiviral Res       Date:  2009-07-01       Impact factor: 5.970

9.  Small interfering RNAs targeting the rabies virus nucleoprotein gene.

Authors:  Yu-Jiao Yang; Ping-Sen Zhao; Tao Zhang; Hua-Lei Wang; Hong-Ru Liang; Li-Li Zhao; Hong-Xia Wu; Tie-Cheng Wang; Song-Tao Yang; Xian-Zhu Xia
Journal:  Virus Res       Date:  2012-08-03       Impact factor: 3.303

10.  Protection of mice against lethal rabies virus challenge using short interfering RNAs (siRNAs) delivered through lentiviral vector.

Authors:  Niraj K Singh; Chetan D Meshram; Arvind A Sonwane; Shyam S Dahiya; Sachin S Pawar; V K Chaturvedi; Mohini Saini; R P Singh; Praveen K Gupta
Journal:  Mol Biotechnol       Date:  2014-02       Impact factor: 2.695

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.